These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 26230475

  • 1. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 2. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X.
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [Abstract] [Full Text] [Related]

  • 3. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, Liu J, Wang Y.
    Int J Clin Exp Pathol; 2015 Jul 30; 8(1):727-34. PubMed ID: 25755767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
    Wang S, Jiao B, Geng S, Song J, Liang Z, Lu S.
    J Neurol Sci; 2014 Mar 15; 338(1-2):71-6. PubMed ID: 24380686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma.
    Tang H, Liu Q, Liu X, Ye F, Xie X, Xie X, Wu M.
    J Cancer Res Ther; 2015 Mar 15; 11(3):630-4. PubMed ID: 26458593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, Qu A, Zhang X, Pan H, Yang Y, Wang C.
    Int J Cancer; 2015 Feb 15; 136(4):854-62. PubMed ID: 24961907
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel serum microRNA-based identification and classification biomarker of human glioma.
    Xing W, Zeng C.
    Tumour Biol; 2017 May 15; 39(5):1010428317705339. PubMed ID: 28475008
    [Abstract] [Full Text] [Related]

  • 19. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
    Sun G, Yan S, Shi L, Wan Z, Jiang N, Li M, Guo J.
    Cancer Biother Radiopharm; 2015 May 15; 30(4):169-73. PubMed ID: 25811315
    [Abstract] [Full Text] [Related]

  • 20. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du F, Liu LJ, Liu YH, Liu XD, Jia JF, Li L, Wu ZL, Zhao G, Zhang ZG, Deng YC.
    J Clin Neurosci; 2013 Jul 15; 20(7):933-7. PubMed ID: 23683741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.